Clinical Trials

Bone Neoplasms, Neoplasms, Connective Tissue, Sarcoma, Osteosarcoma, Neoplasms, Connective and Soft Tissue

NCT06201507 2024-01-12

BV-AVD-R Treatment Children Hodgkin's Lymphoma

44 enrolled

Hodgkin Disease

NCT03420014 2023-10-10

FIBROSARC US

114 enrolled

Leiomyosarcoma

NCT05448820 2023-09-21

YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma

Phase 1/2 Unknown

15 enrolled

Diabetes Mellitus, Insulin-Dependent, 12, Chondrosarcoma, Sarcoma

NCT03226249 2023-06-02

PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma

30 enrolled 10 charts

Hodgkin Disease

NCT05872412 2023-05-25

Effect of Platinum-based Versus Non-platinum-based Neoadjuvant Chemotherapy in Triple-negative Breast Cancer

82 enrolled

Triple Negative Breast Neoplasms

NCT02099175 2023-03-13

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients

41 enrolled

Sinonasal Tumors

NCT02099188 2023-03-13

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients

27 enrolled

Unresectable Sinonasal Tumors

NCT05766605 2023-03-13

Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial

90 enrolled

Hepatocellular Carcinoma Resectable

NCT03412643 2023-03-06

FB-12

64 enrolled

Breast Neoplasms

NCT05701436 2023-03-02

Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial

144 enrolled

Liver, Cancer of, Primary Resectable

NCT05747521 2023-02-28

Anrotinib Hydrochloride Combined With Adriamycin for Neoadjuvant Treatment of High-grade Soft Tissue Sarcoma

Phase NA Unknown

85 enrolled

NCT04012827 2022-09-07

Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma

108 enrolled

NCT01547741 2022-04-14

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

1,871 enrolled

Breast Neoplasms

NCT02499367 2022-03-22

TONIC

84 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT05200312 2022-03-11

ZR2-CHOP

36 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT03542669 2022-03-02

Study of 6b11-OCIK Injection Treatment in Patients With Recurrent Drug-resistant Ovarian Cancer

Phase 1 Unknown

9 enrolled

Gynecologic

Ovarian Neoplasms

NCT02481310 2022-02-21

Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma

Phase 1/2 Unknown

38 enrolled 12 charts

Plasmablastic Lymphoma, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT03837873 2022-01-26

DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma

118 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT03338647 2021-12-02

SBRT or TACE for Advanced HCC

180 enrolled

Carcinoma, Hepatocellular

NCT05138146 2021-11-30

A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma

70 enrolled

NCT05088057 2021-10-21

Neoadjuvant Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer

30 enrolled

Triple Negative Breast Neoplasms

NCT05049473 2021-09-20

Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.

100 enrolled

Burkitt Lymphoma

NCT05006664 2021-09-01

Brentuximab Vedotin in Combination With CHEP in Patient With PTCL

33 enrolled

Lymphoma, T-Cell, Peripheral

NCT00558519 2021-08-18

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Other hematologic neoplasm

318 enrolled 9 charts

Leukemia

NCT05006469 2021-08-16

Observation of the Efficacy of BAd Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma

10 enrolled

Plasma cell

Multiple Myeloma

NCT00324467 2021-07-22

LYTPET

150 enrolled

Lymphoma, Non-Hodgkin

NCT04910126 2021-06-02

Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma

84 enrolled

Sarcoma, Neoplasms, Connective and Soft Tissue

NCT04753177 2021-02-15

The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer

Phase 2/3 Unknown

120 enrolled

The Neoadjuvant Therapy

NCT03294577 2021-01-15

Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia

221 enrolled

Chemotherapy-induced Neutropenia

NCT04025593 2020-11-19

Biomarker Guided Treatment in DLBCL

128 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT00736320 2020-11-04

HD16

1,150 enrolled

Hodgkin Disease

NCT04559308 2020-09-22

The Effect of Metformin on Breast Cancer Patients

80 enrolled

Breast Neoplasms

NCT04498793 2020-09-03

Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer

55 enrolled

HER2-negative Breast Cancer

NCT04358341 2020-08-24

Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer

136 enrolled

Stomach Neoplasms

NCT04356872 2020-07-14

The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma

45 enrolled

Other hematologic neoplasm

NCT04243434 2020-04-16

PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients

Phase 1 Unknown

56 enrolled

Hematologic Diseases, Hematologic Neoplasms

NCT02951728 2020-03-11

DR-CHOP

Phase 1/2 Unknown

58 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT01476410 2020-02-17

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

48 enrolled

Hodgkin Disease

NCT02577783 2020-02-05

PDD vs PAD to Treat Initially Diagnosed MM

Phase 4 Unknown

64 enrolled

Plasma cell

Multiple Myeloma

NCT02918747 2020-01-28

PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage

100 enrolled

Lymphoma

NCT03527628 2019-11-18

(Optimist)

220 enrolled

Hodgkin Disease

NCT02506777 2019-09-04

MBC1

96 enrolled

Breast Neoplasms

NCT03002805 2019-08-19

CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin

Phase 1 Unknown

46 enrolled

Phase EARLY_PHASE1 Unknown

NCT04048317 2019-08-07

Effectiveness of Drug Eluting TACE in Primary HCC

75 enrolled

Carcinoma, Hepatocellular

NCT04021992 2019-08-06

GVD±R Regimen for ASCT-eligible Patients With Refractory/Relapsed DLBCL

48 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT03952572 2019-05-16

Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma

244 enrolled

Lymphoma, T-Cell, Peripheral

NCT03949634 2019-05-14

Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD)

272 enrolled

Breast Neoplasms

NCT01818908 2019-02-15

Trial of DA-EPOCH Regimen for NHL With HLH

50 enrolled

LymphoidMyeloid

Lymphoma, Non-Hodgkin, Lymphohistiocytosis, Hemophagocytic

NCT03617432 2018-09-04

Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients